Form 4 for NVNO enVVeno Medical Corp
Accepted 2021-11-19 00:00:00 ET · period of report 2021-11-19 · accession 0001493152-21-029430 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-19 | 2021-11-19 | NVNO | BERMAN ROBERT ANDREW | CEO, Dir | P - Purchase | $7.43 | +2,000 | 7,736 | +35% | +$14.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-19 | P | A | 2,000 | $7.43 | 7,736 | D | — | — |